185 related articles for article (PubMed ID: 32664343)
1. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.
Pinto MP; Córdova-Delgado M; Retamal IN; Muñoz-Medel M; Bravo ML; Durán D; Villanueva F; Sanchez C; Acevedo F; Mondaca S; Koch É; Ibañez C; Galindo H; Madrid J; Nervi B; Peña J; Torres J; Owen GI; Corvalán AH; Armisén R; Garrido M
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664343
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
[TBL] [Abstract][Full Text] [Related]
3. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS
Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma.
Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A
J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564
[TBL] [Abstract][Full Text] [Related]
7. Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
Di Pinto F; Armentano R; Arborea G; Schena N; Donghia R; Valentini AM
Oncology; 2020; 98(8):566-574. PubMed ID: 32316005
[TBL] [Abstract][Full Text] [Related]
8. Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
Daun T; Nienhold R; Paasinen-Sohns A; Frank A; Sachs M; Zlobec I; Cathomas G
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359622
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes.
Angerilli V; Pennelli G; Galuppini F; Realdon S; Fantin A; Savarino E; Farinati F; Mastracci L; Luchini C; Fassan M
Virchows Arch; 2022 Oct; 481(4):545-552. PubMed ID: 35925389
[TBL] [Abstract][Full Text] [Related]
11. High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study.
Cordova-Delgado M; Pinto MP; Retamal IN; Muñoz-Medel M; Bravo ML; Fernández MF; Cisternas B; Mondaca S; Sanchez C; Galindo H; Nervi B; Ibáñez C; Acevedo F; Madrid J; Peña J; Koch E; Maturana MJ; Romero D; de la Jara N; Torres J; Espinoza M; Balmaceda C; Liao Y; Li Z; Freire M; Gárate-Calderón V; Cáceres J; Sepúlveda-Hermosilla G; Lizana R; Ramos L; Artigas R; Norero E; Crovari F; Armisén R; Corvalán AH; Owen GI; Garrido M
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480291
[TBL] [Abstract][Full Text] [Related]
12. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
[TBL] [Abstract][Full Text] [Related]
15. CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers.
Kim K; Noh S; Cheong JH; Kim H
Gut Liver; 2021 Sep; 15(5):694-704. PubMed ID: 34312322
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.
Hewitt LC; Inam IZ; Saito Y; Yoshikawa T; Quaas A; Hoelscher A; Bollschweiler E; Fazzi GE; Melotte V; Langley RE; Nankivell M; Cunningham D; Allum W; Hutchins GG; Grabsch HI
Eur J Cancer; 2018 May; 94():104-114. PubMed ID: 29550565
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
[TBL] [Abstract][Full Text] [Related]
18. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Han N; Kim MA; Lee HS; Kim WH
Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
[TBL] [Abstract][Full Text] [Related]
19. Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.
Sun Y; Yu W; Guan W; Cai L; Qiao M; Zheng L; Jiang R; Wang R; Wang L
Cancer Manag Res; 2019; 11():6397-6410. PubMed ID: 31372044
[TBL] [Abstract][Full Text] [Related]
20. Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer.
Dislich B; Blaser N; Berger MD; Gloor B; Langer R
Histopathology; 2020 Apr; 76(5):740-747. PubMed ID: 31898331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
